英文名称:MCF7 [MCF-7]
货号:GCL-0149
价格: ¥1600.00 ¥1600.00
产品详情
产品信息
物种 | Human |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:MEM(含NEAA)[GPM150410]+10 μg/mL Insulin[GPB180432]+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
注意事项 |
|
参考资料(来源文献)
背景描述 | MCF7 [MCF-7]细胞保留了多个分化了的乳腺上皮的特性,包括:能通过胞质雌激素受体加工雌二醇并能形成圆形复合物。MCF7 [MCF-7]细胞含有Tx-4癌基因;肿瘤坏死因子α可以抑制MCF7 [MCF-7]细胞的生长,抗雌激素处理MCF7 [MCF-7]细胞能调变IGFBP'S的分泌。 |
年龄(性别) | 69Y |
组织来源 | 乳腺,乳房;源自转移部位:胸腔积液 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | BSL-1 |
抗原表达情况 | Blood Type O; Rh+ |
基因表达情况 | insulin-like growth factor binding proteins (IGFBP) BP-2; BP-4; BP-5 |
受体表达情况 | estrogen receptor, expressed |
保藏机构 | ATCC; CRL-12584 ATCC; HTB-22 BCRC; 60436 BCRJ; 0162 DSMZ; ACC-115 ECACC; 86012803 |
相关文献
-
Role of PAX2 in breast cancer verified by bioinformatics analysis and in vitro validation(2023)
期刊:Annals of Translational Medicine
影响因子:3.600
-
Mutant p53 and ELK1 co-drive FRA-1 Expression to induce metastasis in breast cancer(2023)
期刊:FEBS LETTERS
影响因子:3.5
相关产品: MDA-MB-231 Cells Line, SUM149PT Cells Line, T-47D Cells Line, MCF7 [MCF-7] Cells Line, MCF 10A Cells Line
-
Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells(2023)
期刊:BIOORGANIC & MEDICINAL CHEMISTRY
影响因子:3.5
相关产品: BT-474 [BT474] Cells Line, NCI-H1299 Cells Line, HBE Cells Line, MCF7 [MCF-7] Cells Line, A549 [A-549] Cells Line
-
期刊:FITOTERAPIA
DOI:10.1016/j.fitote.2023.105436
影响因子:3.400
相关产品: MCF7 [MCF-7] Cells Line, MDA-MB-231 Cells Line, MCF-7/ADM Cells Line, MDA-MB-231/ADR Cells Line
-
期刊:FITOTERAPIA
DOI:10.1016/j.fitote.2023.105426
影响因子:3.400
相关产品: MCF7 [MCF-7] Cells Line, MDA-MB-231 Cells Line, MCF-7/ADM Cells Line, MDA-MB-231/ADR Cells Line
-
期刊:CELL TRANSPLANTATION
影响因子:3.3
相关产品: DMEM (High glucose) Medium, Fetal Bovine Serum, HCC1937 Cells Line, DMEM/F12 Medium, RPMI-1640 Medium, MDA-MB-231 Cells Line, Donor Equine Serum, MCF7 [MCF-7] Cells Line, MCF 10A Cells Line
-
TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer(2023)
期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI:10.1016/j.bbrc.2023.149388
影响因子:3.1
相关产品: 4T1 Cells Line, 293T [HEK-293T] Cells Line, MDA-MB-231 Cells Line, MDA-MB-468 Cells Line, BT-549 Cells Line, BT-474 [BT474] Cells Line, MCF7 [MCF-7] Cells Line
-
期刊:Clinical Breast Cancer
DOI:10.1016/j.clbc.2023.04.007
影响因子:3.100
相关产品: MCF 10A Cells Line, MDA-MB-231 Cells Line, MCF7 [MCF-7] Cells Line, SK-BR-3 [SKBR3] Cells Line, THP-1 Cells Line
-
期刊:CANCER CHEMOTHERAPY AND PHARMACOLOGY
DOI:10.1007/s00280-023-04618-4
影响因子:3.0
相关产品: MCF 10A Cells Line, MCF7 [MCF-7] Cells Line, MDA-MB-175VII Cells Line
-
期刊:Chemical Biology & Drug Design
影响因子:3.000
相关产品: MCF 10A Cells Line, MDA-MB-231 Cells Line, MCF7 [MCF-7] Cells Line, Leibovitz's L-15 Complete Medium (10), MEM Complete Medium (10)